| 1 |
Adverse drug reactions to first-line antituberculosis drugs at four DOTS centers in Goa, India |
|
|
| Rupchandra Navelkar, IanAntao Pereira, FrederickSatiro Vaz |
|
| Indian Journal of Health Sciences and Biomedical Research (KLEU). 2023; 16(1): 115 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Analysis of Adverse Drug Reactions associated with Anti-tubercular drugs – A Retrospective Study |
|
|
| Dharini Boopathi, Akshatha J S, Uma Buggi, Hema Siva, Arun K P, Deepalakshmi Mani |
|
| Research Journal of Pharmacy and Technology. 2022; : 1483 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Adverse drug reaction profile of daily regimen antituberculosis treatment |
|
|
| KN Hari Sankar,Kevin Roch,Doyce Jom,DhanyaS Palappallil,Prabitha Panattil,RajaniK Sankaranarayanan |
|
| Perspectives in Clinical Research. 2021; 0(0): 0 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Symptom experience of adverse drug reaction among male and female patients with newly diagnosed pulmonary tuberculosis in Thailand |
|
|
| Apichaya Thontham, Rapin Polsook |
|
| Belitung Nursing Journal. 2021; 7(3): 195 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Evaluation of patient’s experiences with daily DOTS |
|
|
| Akshaya Moorthy,Surabhi Jaggi,Kranti Garg,Mandeep Kaur Sodhi,Deepak Aggarwal,Jagdish Chander |
|
| Indian Journal of Tuberculosis. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
‘Have we missed reporting adverse drug reactions under Revised National TB Control Programme?’ - A mixed method study in Bengaluru, India |
|
|
| Lalitha Krishnappa,Suman Gadicherla,Priyadarshini C,Anuradha HV,Shivaraj NS,Poonam R. Naik,Arundhati Das,Somashekar N,Sharath Burugina Nagaraja |
|
| Indian Journal of Tuberculosis. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Haematological profiles after Intensive phase of Anti Koch Treatment with special emphasis on bone marrow changes |
|
|
| Debjani Basu,Saumitra Biswas,Rudranarayan Ray |
|
| Indian Journal of Tuberculosis. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Spectrum of cutaneous adverse drug reactions to anti-tubercular drugs and safe therapy after re-challenge - A retrospective study |
|
|
| ReenaK Sharma, GhanshyamK Verma, GitaRam Tegta, Samriti Sood, Renu Rattan, Mudita Gupta |
|
| Indian Dermatology Online Journal. 2020; 11(2): 177 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Prevalence of adverse drug reaction with first-line drugs among patients treated for pulmonary tuberculosis |
|
|
| Abhijeet Singh,Rajendra Prasad,Viswesvaran Balasubramanian,Nikhil Gupta,Pawan Gupta |
|
| Clinical Epidemiology and Global Health. 2015; 3: S80 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
THE ANTITUBERCULAR DRUG INDUCED ADVERSE EFFECTS IN REGISTERED CASES UNDER RNTCP – DOTS, PROGRAMME IN BIJAPUR |
|
|
| Nemagouda S |
|
| Journal of Evolution of Medical and Dental Sciences. 2014; 3(19): 5255 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
